M&A Deal Summary |
|
---|---|
Date | 2011-03-01 |
Target | C&J Medicare |
Sector | Healthcare Services |
Buyer(s) | The Abraaj Group |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Asset Manager |
---|---|
Founded | 2002 |
PE ASSETS | 7.4B USD |
Size | Mega |
Type | Sector Agnostic |
Abraaj Capital Limited is a private equity firm that seeks investments in the Middle East, North Africa, and South Asia. Abraaj looks for stable, mature businesses and uses a 'buy and build' strategy for growth. Areas of interest include aerospace, healthcare, transportation, financial services, leisure, education, energy, and manufacturing. In addition to its buyout and growth capital investments, Abraaj also invests in real estate and infrastructure. Abraaj Capital was formed in 2002 and is based in Dubai.
DEAL STATS | # |
---|---|
Overall | 104 of 182 |
Sector (Healthcare Services) | 9 of 24 |
Type (Buyout (LBO, MBO, MBI)) | 95 of 144 |
Country (Ghana) | 4 of 6 |
Year (2011) | 3 of 20 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-03-01 |
Viva Pharmaceutical
BC, Canada Vivapharm (Viva) is a medium-sized, family-run manufacturer of pharmaceuticals and natural products based out of Vancouver, Canada. Viva currently exports to Asia and the Middle East and is investing in another facility in Brunei to take advantage of the proximity of the markets it is targeting. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-04-01 |
Unimed
Sousse, Tunisia Unimed is a leading player in sterile form products. It has more than 60 drug registrations covering mainly liquid injectables, powder injectables and eye drops. The company largely addresses the needs of domestic hospitals and private markets and carries out contract manufacturing for large international pharmaceutical companies such as Pfizer, Mylan and Théa. |
Buy | - |